CareKinesis Webinar Series: Hepatitis C Virus (HCV) Therapy Guidance and Cost-Effectiveness Considerations – Session 2

30 October 2018

CareKinesis Webinar Series: Hepatitis C Virus (HCV) Therapy Guidance and Cost-Effectiveness Considerations – Session 2

When:
November 12, 2018 @ 3:00 pm – 4:00 pm
2018-11-12T15:00:00-05:00
2018-11-12T16:00:00-05:00

Join us on Monday, November 12, 2018 for webinars on Hepatitis C Virus (HCV) Therapy Guidance and Cost-Effectiveness Considerations.

Times:

  • 12:00 – 1:00 pm EST
  • 3:00 – 4:00 pm EST

The webinar will provide an overview of topics that will help the attendee:

  • Describe the healthcare industry’s role in preventing and controlling the spread of Hepatitis C.
  • Explain the cost-effectiveness considerations for Hepatitis C treatment regimens.
  • Differentiate available Hepatitis C treatment regimens, including FDA-approved indications, mechanism of action, and clinical pearls.
  • Review guideline-based approaches to Hepatitis C treatment.

Speaker:
Lisa A. Banks, PharmD, BCGP, VP Clinical Initiatives, CareKinesis

Register now!